As last captured

Money Laundering, Terrorist Financing and Transfer of Funds... · PART 5 Beneficial Ownership Information

42 Application of this Part

reg. 42 · in force: yes

Captured statutory text (L5)

42 Application of this Part

(1)This Part applies to UK bodies corporate and relevant trusts.
(2)For the purposes of this Part—
(a)a “UK body corporate” is a body corporate which is incorporated under the law of the United Kingdom or any part of the United Kingdom, and includes an eligible Scottish partnership;
(b)a “relevant trust” is—
(i)a UK trust which is an express trust; ...
(ii)a non-UK trust which is an express trust; and
(aa)receives income from a source in the United Kingdom; or
(bb)has assets in the United Kingdom,
on which it is liable to pay one or more of the taxes referred to in regulation 45(14); or
(iii)any other non-UK trust which is an express trust, is not a trust listed in Schedule 3A (excluded trusts) and whose trustees (in their capacity as such)—
(aa)acquire an interest in land in the United Kingdom; ...
(aaa)acquired an interest in land in the United Kingdom before 6th October 2020 and continued to hold that interest up to and including the date on which this sub-paragraph comes into force; or
(bb)enter into a business relationship with a relevant person, where at least one of those trustees is resident in the United Kingdom and the trust is not an EEA registered trust;
(c)a trust is a “UK trust” if—
(i)all the trustees are resident in the United Kingdom; or
(ii)sub-paragraph (d) applies;
(d)this sub-paragraph applies if—
(i)at least one trustee is resident in the United Kingdom, and
(ii)the settlor was resident ... in the United Kingdom at the time when—
(aa)the trust was set up, or
(bb)the settlor added funds to the trust;
(e)a trust is a “non-UK trust” if it is not a UK trust;
(f)a “collective investment scheme” has the meaning given in regulation 12H of the International Tax Compliance Regulations 2015 .
(2A)In relation to a trust that was set up before 6 April 2025, paragraph (2)(d)(ii) has effect as if after “resident” there were inserted “and domiciled”.
(3)A trustee or settlor is resident in the United Kingdom—
(a)in the case of a body corporate, if it is a UK body corporate;
(b)in the case of an individual, if the individual is resident in the United Kingdom for the purposes of one or more of the taxes referred to in regulation 45(14).
(4)For the purposes of this Part, an “EEA registered trust” is a trust established in a country or territory other than the United Kingdom where national legislation applies having a broadly equivalent effect to the requirements laid down in the fourth money laundering directive.
(5)For the purposes of this Part, the trustees acquire an interest in land in the United Kingdom where at least one of the trustees becomes registered—
(a)in the register of title kept under the Land Registration Act 2002 as the proprietor of—
(i)a freehold estate in land; or
(ii)a leasehold estate in land granted for a term of more than 7 years from the date of the grant;
(b)in the Land Register of Scotland as the proprietor or as the tenant under a lease (“lease” and “proprietor” having the meanings given by section 113(1) of the Land Registration etc. (Scotland) Act 2012); or
(c)in the register kept under the Land Registration Act (Northern Ireland) 1970 as the owner of—
(i)a freehold estate in land; or
(ii)a leasehold estate in land granted for a term of more than 21 years from the date of the grant.
(6)For the purposes of this Part—
(a)the trustees have a controlling interest in a third country entity if they meet any of the specified conditions in paragraphs 2 to 5 of Schedule 1A to the Companies Act 2006 (people with significant control over a company) where that Schedule is read with the following modifications—
(i)references to X having or holding a share in or a right in relation to, or exercising significant influence or control over, company Y are to be read as references to the trustees (in their capacity as such) having or holding a share in or a right in relation to, or exercising significant influence or control over, the third country entity;
(ii)for “25%” wherever it occurs in each of paragraphs 2 (ownership of shares), 3 (voting rights), 13 (calculating shareholdings), and 14 (voting rights), read “50%”; and
(b)“third country entity” means a body corporate, partnership or other entity that—
(i)is governed by the law of a country or territory other than the United Kingdom and (in each case) is a legal person under that law, and
(ii)is not subject to national legislation having a broadly equivalent effect to the requirements laid down in Article 30 of the fourth money laundering directive.
Full captured verbatim text
(1) This Part applies to UK bodies corporate and relevant trusts.

(2) For the purposes of this Part—

(a) a “UK body corporate” is a body corporate which is incorporated under the law of the United Kingdom or any part of the United Kingdom, and includes an eligible Scottish partnership;

(b) a “relevant trust” is—

(i) a UK trust which is an express trust; ...

(ii) a non-UK trust which is an express trust; and

(aa) receives income from a source in the United Kingdom; or

(bb) has assets in the United Kingdom,

on which it is liable to pay one or more of the taxes referred to in regulation 45(14); or

(iii) any other non-UK trust which is an express trust, is not a trust listed in Schedule 3A (excluded trusts) and whose trustees (in their capacity as such)—

(aa) acquire an interest in land in the United Kingdom; ...

(aaa) acquired an interest in land in the United Kingdom before 6th October 2020 and continued to hold that interest up to and including the date on which this sub-paragraph comes into force; or

(bb) enter into a business relationship with a relevant person, where at least one of those trustees is resident in the United Kingdom and the trust is not an EEA registered trust;

(c) a trust is a “UK trust” if—

(i) all the trustees are resident in the United Kingdom; or

(ii) sub-paragraph (d) applies;

(d) this sub-paragraph applies if—

(i) at least one trustee is resident in the United Kingdom, and

(ii) the settlor was resident ... in the United Kingdom at the time when—

(aa) the trust was set up, or

(bb) the settlor added funds to the trust;

(e) a trust is a “non-UK trust” if it is not a UK trust;

(f) a “collective investment scheme” has the meaning given in regulation 12H of the International Tax Compliance Regulations 2015 .

(2A) In relation to a trust that was set up before 6 April 2025, paragraph (2)(d)(ii) has effect as if after “resident” there were inserted “and domiciled”.

(3) A trustee or settlor is resident in the United Kingdom—

(a) in the case of a body corporate, if it is a UK body corporate;

(b) in the case of an individual, if the individual is resident in the United Kingdom for the purposes of one or more of the taxes referred to in regulation 45(14).

(4) For the purposes of this Part, an “EEA registered trust” is a trust established in a country or territory other than the United Kingdom where national legislation applies having a broadly equivalent effect to the requirements laid down in the fourth money laundering directive.

(5) For the purposes of this Part, the trustees acquire an interest in land in the United Kingdom where at least one of the trustees becomes registered—

(a) in the register of title kept under the Land Registration Act 2002 as the proprietor of—

(i) a freehold estate in land; or

(ii) a leasehold estate in land granted for a term of more than 7 years from the date of the grant;

(b) in the Land Register of Scotland as the proprietor or as the tenant under a lease (“lease” and “proprietor” having the meanings given by section 113(1) of the Land Registration etc. (Scotland) Act 2012); or

(c) in the register kept under the Land Registration Act (Northern Ireland) 1970 as the owner of—

(i) a freehold estate in land; or

(ii) a leasehold estate in land granted for a term of more than 21 years from the date of the grant.

(6) For the purposes of this Part—

(a) the trustees have a controlling interest in a third country entity if they meet any of the specified conditions in paragraphs 2 to 5 of Schedule 1A to the Companies Act 2006 (people with significant control over a company) where that Schedule is read with the following modifications—

(i) references to X having or holding a share in or a right in relation to, or exercising significant influence or control over, company Y are to be read as references to the trustees (in their capacity as such) having or holding a share in or a right in relation to, or exercising significant influence or control over, the third country entity;

(ii) for “25%” wherever it occurs in each of paragraphs 2 (ownership of shares), 3 (voting rights), 13 (calculating shareholdings), and 14 (voting rights), read “50%”; and

(b) “third country entity” means a body corporate, partnership or other entity that—

(i) is governed by the law of a country or territory other than the United Kingdom and (in each case) is a legal person under that law, and

(ii) is not subject to national legislation having a broadly equivalent effect to the requirements laid down in Article 30 of the fourth money laundering directive.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 2/3 · detailed summary (L4) Status: failed · Stored artifact; current recipe verification unavailable

Defines the application of Part 5 across UK bodies corporate, relevant trusts, UK trusts, and controlling interests in third country entities.

Only the one-line summary above is stored for this provision; the text itself is the evidence.

Refers to

other law external_cite · s. 113

other law external_cite · Sch. 1A para. 1

other law external_cite · Sch. 1A para. 10

other law external_cite · Sch. 1A para. 11

other law external_cite · Sch. 1A para. 12

other law external_cite · Sch. 1A para. 13

other law external_cite · Sch. 1A para. 14

other law external_cite · Sch. 1A para. 15

other law external_cite · Sch. 1A para. 16

other law external_cite · Sch. 1A para. 17

other law external_cite · Sch. 1A para. 18

other law external_cite · Sch. 1A para. 19

other law external_cite · Sch. 1A para. 2

other law external_cite · Sch. 1A para. 20

other law external_cite · Sch. 1A para. 21

other law external_cite · Sch. 1A para. 22

other law external_cite · Sch. 1A para. 23

other law external_cite · Sch. 1A para. 24

other law external_cite · Sch. 1A para. 25

other law external_cite · Sch. 1A para. 26

other law external_cite · Sch. 1A para. 3

other law external_cite · Sch. 1A para. 4

other law external_cite · Sch. 1A para. 5

other law external_cite · Sch. 1A para. 6

other law external_cite · Sch. 1A para. 7

other law external_cite · Sch. 1A para. 8

other law external_cite · Sch. 1A para. 9

cross-reference internal_cite · reg. 45

schedule ref schedule_ref · Sch. 3A para. 1

schedule ref schedule_ref · Sch. 3A para. 10

schedule ref schedule_ref · Sch. 3A para. 11

schedule ref schedule_ref · Sch. 3A para. 12

schedule ref schedule_ref · Sch. 3A para. 13

schedule ref schedule_ref · Sch. 3A para. 14

schedule ref schedule_ref · Sch. 3A para. 15

schedule ref schedule_ref · Sch. 3A para. 16

schedule ref schedule_ref · Sch. 3A para. 17

schedule ref schedule_ref · Sch. 3A para. 18

schedule ref schedule_ref · Sch. 3A para. 19

schedule ref schedule_ref · Sch. 3A para. 1A

schedule ref schedule_ref · Sch. 3A para. 2

schedule ref schedule_ref · Sch. 3A para. 20

schedule ref schedule_ref · Sch. 3A para. 21

schedule ref schedule_ref · Sch. 3A para. 22

schedule ref schedule_ref · Sch. 3A para. 23

schedule ref schedule_ref · Sch. 3A para. 23A

schedule ref schedule_ref · Sch. 3A para. 24

schedule ref schedule_ref · Sch. 3A para. 3

schedule ref schedule_ref · Sch. 3A para. 4

schedule ref schedule_ref · Sch. 3A para. 5

schedule ref schedule_ref · Sch. 3A para. 6

schedule ref schedule_ref · Sch. 3A para. 6A

schedule ref schedule_ref · Sch. 3A para. 7

schedule ref schedule_ref · Sch. 3A para. 8

schedule ref schedule_ref · Sch. 3A para. 8A

schedule ref schedule_ref · Sch. 3A para. 9

schedule ref schedule_ref · Sch. 3A para. 9A

schedule ref schedule_ref · Sch. 3A para. 9B

Referred to by

cross-reference internal_cite · Sch. 3A para. 6

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (348)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-6

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-7

synthesis coverage: missing/unverified L2 part-2-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-9

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-10

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-12

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-13

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-15

synthesis coverage: missing/unverified L2 part-2-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-17

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-20

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-21

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-22

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-23

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-24

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-25

synthesis coverage: missing/unverified L2 part-2-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-26

synthesis coverage: missing/unverified L2 part-3-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-27

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-28

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-29

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-31

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-32

synthesis coverage: missing/unverified L2 part-3-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-33

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-34

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-35

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-36

synthesis coverage: missing/unverified L2 part-3-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-37

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-38

synthesis coverage: missing/unverified L2 part-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-39

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-40

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-41

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-42

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-43

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-44

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZB

synthesis coverage: missing/unverified L2 part-5A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45F

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45G

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45H

synthesis coverage: missing/unverified L2 part-6-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-47

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-48

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-49

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-50

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-51

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52B

synthesis coverage: missing/unverified L2 part-6-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-53

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-54

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-55

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-57

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-59

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60

synthesis coverage: missing/unverified L2 part-6-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60B

synthesis coverage: missing/unverified L2 part-7

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-61

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-62

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-63

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64

synthesis coverage: missing/unverified L2 part-7A-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64B

synthesis coverage: missing/unverified L2 part-7A-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64F

synthesis coverage: missing/unverified L2 part-7A-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64G

synthesis coverage: missing/unverified L2 part-7A-chapter-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64H

synthesis coverage: missing/unverified L2 part-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-65

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-66

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-67

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-68

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-69

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-70

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-71

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-72

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-73

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74C

synthesis coverage: missing/unverified L2 part-9-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-75

synthesis coverage: missing/unverified L2 part-9-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-76

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-77

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-78

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-79

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-80

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-81

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-82

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-83

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-84

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-85

synthesis coverage: missing/unverified L2 part-9-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-86

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-87

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-88

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-89

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-90

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-91

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-92

synthesis coverage: missing/unverified L2 part-10-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-93

synthesis coverage: missing/unverified L2 part-10-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-94

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-95

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-96

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-97

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-98

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-99

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-100

synthesis coverage: missing/unverified L2 part-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-101

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-102

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-103

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-105

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-106

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-107

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-108

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-109

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-110

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-29

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-35

synthesis coverage: missing/unverified L2 schedule-3AZA

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-3

synthesis coverage: missing/unverified L2 schedule-3A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-24

synthesis coverage: missing/unverified L2 schedule-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-19

synthesis coverage: missing/unverified L2 schedule-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-4

synthesis coverage: missing/unverified L2 schedule-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-13

synthesis coverage: missing/unverified L2 schedule-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-16

synthesis coverage: missing/unverified L2 schedule-6B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-5

synthesis coverage: missing/unverified L2 schedule-7-part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-11

synthesis coverage: missing/unverified L2 schedule-7-part-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-35

Instrument tier unavailable

Change history as published

Reg. 22 omitted (31.12.2020) by virtue of The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/253), regs. 1(2), 5(4) (with savings in S.I. 2019/680, reg. 11); 2020 c. 1, Sch. 5 para. 1(1)

Pt. 5A omitted (1.9.2022) by virtue of The Money Laundering and Terrorist Financing (Amendment) (No. 2) Regulations 2022 (S.I. 2022/860), regs. 1(5), 10 · repeated 8×

Sch. 7 para. 27 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

reg. 3(1) words inserted by The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 reg. 3(b) · Effective date unknown · reg. 3

reg. 34A inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 20 · Effective date unknown

Sch. 6 para. 7(ga) inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 36(b) · Effective date unknown · Sch. 6 para. 7

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument
uk:uksi/2017/692
Part
PART 5 Beneficial Ownership Information
Version
c5a0271554697d8359bede8a…
Content hash
sha256 bcbf003fcdf1e23b511ecfdd…
Source
legislation.gov.uk/uksi/2017/692